In these studies we report that high stromal expression of PDGFRβ and hyaluronan, both in the tumor stroma and in the stroma of the surrounding non-malignant tissue, was associated with a poor outcome of prostate cancer patients. Here, PDGFRB is linked to prostate cancer.